Charlotte Nichols MP: written questions

248 published records · newest first.

Written questions

  • ADHD: DiagnosisDepartment of Health and Social CareTabled 16 Dec 2025AnsweredUIN 100441More

    Question: To ask the Secretary of State for Health and Social Care, what is the average waiting time for an ADHD assessment in a) England, b) the North West and c) the Cheshire and Merseyside Integrated Care Board area.

    Answer: For the first time, NHS England published management information on attention deficit hyperactivity disorder (ADHD) waits at a national level on 29 May 2025 as part of its ADHD data improvement plan, and has also released technical guidance to integrated ...

    Answered 13 Jan 2026

    Original Parliament record
  • ADHD: DiagnosisDepartment of Health and Social CareTabled 16 Dec 2025AnsweredUIN 100440More

    Question: To ask the Secretary of State for Health and Social Care, how many people are on a waiting list for an ADHD assessment in a) England, b) the North West and c) the Cheshire and Merseyside Integrated Care Board area.

    Answer: For the first time, NHS England published management information on attention deficit hyperactivity disorder (ADHD) waits at a national level on 29 May 2025 as part of its ADHD data improvement plan, and has also released technical guidance to integrated ...

    Answered 13 Jan 2026

    Original Parliament record
  • Sewage: Pollution ControlDepartment for Environment, Food and Rural AffairsTabled 16 Dec 2025AnsweredUIN 100412More

    Question: To ask the Secretary of State for Environment, Food and Rural Affairs, what recent discussions she has had with utility companies on investing their profits into sewage spill prevention and improving infrastructure.

    Answer: The Secretary of State regularly meets with stakeholders including water companies to discuss a range of issues. £104 billion is being invested to upgrade crumbling pipes and sewage treatment works across the country. This includes over £10 billion to imp...

    Answered 6 Jan 2026

    Original Parliament record
  • IVF: SurrogacyDepartment of Health and Social CareTabled 15 Dec 2025AnsweredUIN 99884More

    Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure equitable access to funding for IVF surrogacy for people post cancer treatment.

    Answer: Funding decisions for fertility services, including cases where a surrogate may be involved, are made by integrated care boards (ICBs), which are responsible for commissioning services based on the clinical needs of their populations. We expect ICBs to co...

    Answered 22 Dec 2025

    Original Parliament record
  • Rockstar Games: DismissalDepartment for Business and TradeTabled 15 Dec 2025AnsweredUIN 99869More

    Question: To ask the Secretary of State for Business and Trade, whether he plans to provide support to people who claim to have been sacked for trying to unionise whilst working at Rockstar North.

    Answer: The government is looking into the matters in relation to Rockstar North. Section 152 of the Trade Union Labour Relations (Consolidation) Act 1992 protects employees from dismissal for being or seeking to be a member of a trade union. An employee who cons...

    Answered 23 Dec 2025

    Original Parliament record
  • Evri: Minimum WageDepartment for Business and TradeTabled 15 Dec 2025AnsweredUIN 99868More

    Question: To ask the Secretary of State for Business and Trade, whether he has had recent discussions with Evri on paying their workers the minimum wage.

    Answer: The passing of the Employment Rights Act, and measures such as the creation of the Fair Work Agency, will create an economy that balances flexibility and security. In doing so, we will ensure an environment where working people and businesses can succeed ...

    Answered 2 Jan 2026

    Original Parliament record
  • Delivery Services: StandardsDepartment for Business and TradeTabled 15 Dec 2025AnsweredUIN 99867More

    Question: To ask the Secretary of State for Business and Trade, what discussions he has had with Evri and other delivery companies on leaving parcels unattended on doorsteps.

    Answer: It is unacceptable for delivery companies to leave parcels unattended on doorsteps where that has not been requested by a customer. The government wants to see all operators provide a good level of service, including incorporating customers’ preferences o...

    Answered 18 Dec 2025

    Original Parliament record
  • VorasidenibDepartment of Health and Social CareTabled 11 Dec 2025AnsweredUIN 99268More

    Question: To ask the Secretary of State for Health and Social Care, when he expects the drug Vorsidenib (Voranigo) to be made available to treat adults and children aged 12 years and over with grade 2 astrocytoma or oligodendroglioma carrying a susceptible IDH1 or

    Answer: The National Institute for Health and Care Excellence (NICE) is the independent body that makes evidence-based recommendations on whether new medicines should be routinely funded by the National Health Service based on an assessment of clinical and cost e...

    Answered 18 Dec 2025

    Original Parliament record
  • Naloxone: Public ConsultationDepartment of Health and Social CareTabled 24 Nov 2025AnsweredUIN 93958More

    Question: To ask the Secretary of State for Health and Social Care, when he plans to publish a consultation on access to naloxone.

    Answer: Naloxone is a lifesaving medicine that reverses the effects of an opioid overdose, including highly potent synthetic opioids which are growing in prevalence in the United Kingdom. It is more important than ever to increase access to naloxone products, whi...

    Answered 19 Jan 2026

    Original Parliament record
  • NaloxoneDepartment of Health and Social CareTabled 24 Nov 2025AnsweredUIN 93957More

    Question: To ask the Secretary of State for Health and Social Care, what his planned timeline is for the establishment of the naloxone supply network coordinators.

    Answer: Naloxone is a lifesaving medicine that reverses the effects of an opioid overdose, including highly potent synthetic opioids which are growing in prevalence in the United Kingdom. It is more important than ever to increase access to naloxone products, whi...

    Answered 9 Dec 2025

    Original Parliament record
  • Employment: MenopauseWomen and EqualitiesTabled 18 Nov 2025AnsweredUIN 92240More

    Question: To ask the Minister for Women and Equalities, what measures the Government is taking to ensure that employers are supporting women managing menopause in the workplace.

    Answer: We know that support in the workplace during the menopause can be crucial. That is why we will require large employers to detail the steps they are taking to support their staff during the menopause as part of an action plan. These will be introduced on a...

    Answered 26 Nov 2025

    Original Parliament record
  • Flexible Working: WomenDepartment for Business and TradeTabled 18 Nov 2025AnsweredUIN 92239More

    Question: To ask the Secretary of State for Business and Trade, what steps the Government is taking to support women in the workplace with flexible working.

    Answer: Flexible working can make work more inclusive for those facing barriers to staying in and getting on at work, including women navigating parenthood, caring responsibilities, health conditions, and other personal circumstances.We are changing legislation t...

    Answered 26 Nov 2025

    Original Parliament record
  • Employment: Sexual HarassmentWomen and EqualitiesTabled 18 Nov 2025AnsweredUIN 92238More

    Question: To ask the Minister for Women and Equalities, what steps the Government is taking to ensure employers are taking a proactive and preventative approach to protecting their employees from workplace sexual harassment.

    Answer: On 26 October 2024, the Worker Protection (Amendment to the Equality Act 2010) Act 2023 came into force. This inserted a new section 40A into the Equality Act 2010 which requires employers to anticipate the risk of sexual harassment occurring and take ste...

    Answered 26 Nov 2025

    Original Parliament record
  • Public Sector: ProcurementCabinet OfficeTabled 18 Nov 2025AnsweredUIN 92237More

    Question: To ask the Minister for the Cabinet Office, what steps he is taking to ensure that public contracts are not awarded to companies that blacklist workers.

    Answer: This Government is committed to ensuring public procurement supports British jobs and industry. Under the exclusion regime in the Procurement Act 2023, contracting authorities may exclude suppliers for blacklisting offences. The exclusion regime came into...

    Answered 26 Nov 2025

    Original Parliament record
  • Coronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88871More

    Question: To ask the Secretary of State for Health and Social Care, when the database of AstraZeneca covid-19 vaccine side effects was last updated.

    Answer: The Medicines and Healthcare products Regulatory Agency is responsible for monitoring all authorised medicines and vaccines in the United Kingdom, including the AstraZeneca COVID-19 vaccines, on an ongoing basis to ensure their benefits continue to outwei...

    Answered 20 Nov 2025

    Original Parliament record
  • Vaccine Damage Payment SchemeDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88870More

    Question: To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of approval rates for covid-19 vaccine injury claims in (a) the UK and (b) other jurisdictions for which figures are available.

    Answer: No specific assessment has been made. All claims made through the Vaccine Damage Payment Scheme are assessed on a case-by-case basis by independent medical assessors. Medical assessors must be General Medical Council registered doctors with a licence to p...

    Answered 18 Nov 2025

    Original Parliament record
  • Vaccine Damage Payment SchemeDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88869More

    Question: To ask the Secretary of State for Health and Social Care, what the rate for (a) approval of claims, (b) claims overturned at review and (c) payout has been for the Vaccine Damage Payment Scheme since March 2022.

    Answer: The Vaccine Damage Payment Scheme (VDPS) provides a one-off, tax-free payment of £120,000 to claimants who have been found, in rare cases and on the balance of probabilities, to have been severely disabled by certain vaccines for a disease listed in the V...

    Answered 18 Nov 2025

    Original Parliament record
  • VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88868More

    Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to make (a) apheresis and (b) immunoabsorption treatments available for vaccine damage patients when doctors feel it would be beneficial.

    Answer: In the very rare event where an individual may have suffered a severe adverse reaction to a COVID-19 vaccine, care and treatment will be managed by National Health Service local specialist services, augmented as appropriate by national specialist advice, ...

    Answered 19 Nov 2025

    Original Parliament record
  • Coronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88867More

    Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) approve and (b) fund specialist treatments for AstraZeneca vaccine damage.

    Answer: In the very rare event where an individual may have suffered a severe adverse reaction to a COVID-19 vaccine, care and treatment will be managed by National Health Service local specialist services, augmented as appropriate by national specialist advice, ...

    Answered 19 Nov 2025

    Original Parliament record
  • Coronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88866More

    Question: To ask the Secretary of State for Health and Social Care, whether his Department is undertaking research into (a) damage and (b) lasting effects from the AstraZeneca vaccine.

    Answer: Vaccines are only authorised once they have met robust standards of effectiveness, safety, and quality set by the independent medicines’ regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).The monitoring of vaccine safety does not st...

    Answered 18 Nov 2025

    Original Parliament record
  • Vaccine Damage Payment SchemeDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88865More

    Question: To ask the Secretary of State for Health and Social Care, what the medical experience requirements are for caseworkers handling vaccine damage payment claims.

    Answer: Caseworkers supporting the Vaccine Damage Payment Scheme (VDPS) are administrative staff who are not involved in the assessment of claims. Their role is to provide claimants with a consistent point of contact, manage the administrative progress of claims,...

    Answered 18 Nov 2025

    Original Parliament record
  • Coronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88864More

    Question: To ask the Secretary of State for Health and Social Care, how often the database of AstraZeneca covid vaccine side effects has been updated in each year since 2020.

    Answer: The Medicines and Healthcare products Regulatory Agency is responsible for monitoring all authorised medicines and vaccines in the United Kingdom, including the AstraZeneca COVID-19 vaccines, on an ongoing basis to ensure their benefits continue to outwei...

    Answered 20 Nov 2025

    Original Parliament record
  • Coronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88863More

    Question: To ask the Secretary of State for Health and Social Care, what research his Department is undertaking into side affects of the AstraZenica covid vaccine; through what process his Department are recognising emerging side effects; and if he will make a stat

    Answer: Vaccines are only authorised once they have met robust standards of effectiveness, safety, and quality set by the independent medicines’ regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).The monitoring of vaccine safety does not st...

    Answered 18 Nov 2025

    Original Parliament record
  • Nuclear Decommissioning Authority: Redundancy PayDepartment for Energy Security and Net ZeroTabled 10 Nov 2025AnsweredUIN 88862More

    Question: To ask the Secretary of State for Energy Security and Net Zero, what discussions he had with the Group Chief Executive Officer of the Nuclear Decommissioning Authority on the implementation of that organisation's voluntary exit scheme before it was introd

    Answer: Details of Ministers' and Permanent Secretaries' meetings with external individuals and organisations are published quarterly in arrears on GOV.UK. As part of this approach, the NDA has introduced voluntary exit schemes across its group to support organis...

    Answered 18 Nov 2025

    Original Parliament record
  • Trawsfynydd Power Station: DecommissioningDepartment for Energy Security and Net ZeroTabled 10 Nov 2025AnsweredUIN 88861More

    Question: To ask the Secretary of State for Energy Security and Net Zero, whether his Department has carried out an assessment of the potential impact of the Nuclear Decommissioning Authority estate's voluntary exit scheme on the (a) delivery of objectives and (b)

    Answer: The Nuclear Decommissioning Authority (NDA) remains focused on delivering its statutory mission to keep former nuclear sites safe and secure while progressing decommissioning and managing waste. To achieve this efficiently, the NDA has introduced voluntar...

    Answered 18 Nov 2025

    Original Parliament record

Published records only — not a full account of an MP’s work. How we work →